Loading provider…
Loading provider…
Ophthalmology Physician in North Bergen, NJ
NPI: 1285642470Primary Employer
Retina Center of New Jersey, LLC
retinacenternj.com
HQ Phone
Get MD Patrick's Phone Numberphone_androidMobile
Get MD Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
Rutgers New Jersey Medical School
njms.rutgers.edu
Residency • Ophthalmology
1994 - 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 656 | 1,632 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 599 | 1,420 |
| 3 | 92202Extended examination of eye with drawing of optic nerve and surrounding area (macula) | 378 | 567 |
| 4 | 67028Injection of drug into eye | 238 | 1,077 |
| 5 | 92201Extended examination of eye with drawing of retina | 196 | 222 |
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
Authors: David Brown, David Boyer, Michael Singer, Charles Wykoff
Publication Date: 2021-09
Authors: Shmushkevich, Shon, Berzack, Shannan, Bajrami, Sandi, Higgins, Patrick, Wagner, Rudolph S
Journal: J Pediatr Ophthalmol Strabismus
Publication Date: 2025-06-27
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Bayer
Intervention / Treatment: DRUG: High-dose aflibercept, DRUG: aflibercept
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Intravitreal Aflibercept Injection (IAI), DRUG: REGN910-3
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Sham, DRUG: Intravitreal aflibercept injection [IAI]